SNO-EANO-EURACAN consensus on management of pineal parenchymal tumors.

clinical treatment guidelines papillary tumor of pineal region pineal cyst pineal parenchymal tumors risk-stratification

Journal

Neuro-oncology
ISSN: 1523-5866
Titre abrégé: Neuro Oncol
Pays: England
ID NLM: 100887420

Informations de publication

Date de publication:
29 Jul 2024
Historique:
medline: 29 7 2024
pubmed: 29 7 2024
entrez: 29 7 2024
Statut: aheadofprint

Résumé

Pineal parenchymal tumors are rare neoplasms for which evidence-based treatment recommendations are lacking. These tumors vary in biology, clinical characteristics, and prognosis, requiring treatment that ranges from surgical resection alone to intensive multimodal antineoplastic therapy. Recently, international collaborative studies have shed light on the genomic landscape of these tumors, leading to refinement in molecular-based disease classification in the 5th edition of the World Health Organization (WHO) classification of tumors of the central nervous system. In this review, we summarize the literature on diagnostic and therapeutic approaches, and suggest pragmatic recommendations for the clinical management of patients presenting with intrinsic pineal region masses including parenchymal tumors (pineocytoma, pineal parenchymal tumor of intermediate differentiation, and pineoblastoma), pineal cyst, and papillary tumors of the pineal region.

Identifiants

DOI: 10.1093/neuonc/noae128 PMID: 39073785
pubmed: 39073785
pii: 7723335
doi: 10.1093/neuonc/noae128
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Anthony P Y Liu (APY)

Department of Paediatrics and Adolescent Medicine, School of Clinical Medicine, The University of Hong Kong, Hong Kong, China.
Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
ORCID: 0000-0002-8597-9128

Bryan K Li (BK)

Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Alexandre Vasiljevic (A)

Service D'Anatomie Et Cytologie Pathologiques, CHU de Lyon, Lyon, France.
Faculté de Médecine Lyon Est, Université Claude Bernard, Lyon, France.

Michael C Dewan (MC)

Division of Pediatric Neurological Surgery, Vanderbilt University Medical Center, Tennessee, USA.

Benita Tamrazi (B)

Department of Radiology, Children's Hospital Los Angeles, Los Angeles, California, USA.

Birgit Ertl-Wagner (B)

Division of Neuroradiology, Department of Diagnostic & Interventional Neuroradiology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Neurosciences and Mental Health Program, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
ORCID: 0000-0002-7896-7049

Jordan R Hansford (JR)

Michael Rice Centre for Hematology and Oncology, Women's and Children's Hospital; South Australia Health and Medical Research Institute; South Australia Immunogenomics Cancer Institute, University of Adelaide, Adelaide, South Australia, Australia.

Elke Pfaff (E)

Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Pediatric Glioma Research Group (B360), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.

Martin Mynarek (M)

Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department for Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID: 0000-0003-3302-2719

Ho-Keung Ng (HK)

Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China.

Derek S Tsang (DS)

Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

Nicholas G Gottardo (NG)

Department of Pediatric & Adolescent Oncology and Haematology, Perth Children's Hospital and Brain Tumor Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, University of Western Australia, Perth, Western Australia, Australia.

Amar Gajjar (A)

Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

Eric Bouffet (E)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
ORCID: 0000-0002-6832-6539

Christelle Dufour (C)

Department of Pediatric and Adolescent Oncology, Gustave Roussy, France.
INSERM, Molecular Predictors and New Targets in Oncology, Paris-Saclay University, Villejuif, France.
ORCID: 0000-0001-5993-8077

Barry Pizer (B)

School of Life Sciences, University of Liverpool, Liverpool, UK.

David Schiff (D)

Division of Neuro-Oncology, Department of Neurology, University of Virginia, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
ORCID: 0000-0003-1561-9220

Michael D Jenkinson (MD)

Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK.
Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.

Giuseppe Lombardi (G)

Department of Medical Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.
ORCID: 0000-0003-1316-2132

Patrick Y Wen (PY)

Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Martin J van den Bent (MJ)

The Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Dr molewaterplein 40, Rotterdam, The Netherlands.
ORCID: 0000-0001-5710-5127

Annie Huang (A)

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Medical Biophysics, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Classifications MeSH